Skip to main content
. 2019 Oct 31;6(4):453–465. doi: 10.3233/JND-190416

Fig.4.

Fig.4

A and B: Levels of (A) pTau and (B) NSE at baseline, visit 4, visit 5 and visit 6. Boxplots of the levels of (A) neuron specific enolase (NSE) and (B) phosphorylated TAU-Protein (pTau) at baseline, visit 4, visit 5 and visit 6, both measured in cerebral fluid. For pTAU, there was a significant decrease between baseline and visit 4 as well as visit 6. For NSE, we could detect a significant decrease in all visits compared to baseline.